Elkem 過去の業績
過去 基準チェック /16
Elkemの収益は年間平均-27.6%の割合で減少していますが、 Chemicals業界の収益は年間 増加しています。収益は年間0.2% 18.6%割合で 減少しています。 Elkemの自己資本利益率は1.7%であり、純利益率は2%です。
主要情報
-27.60%
収益成長率
-27.96%
EPS成長率
| Chemicals 業界の成長 | 32.60% |
| 収益成長率 | -18.64% |
| 株主資本利益率 | 1.71% |
| ネット・マージン | 2.03% |
| 次回の業績アップデート | 10 Jul 2026 |
最近の業績更新
Recent updates
ナラティブの更新 • May 15
ELK: Equity Raise And Biocarbon Project Will Support Future Upside
Elkem's updated analyst price target has shifted from NOK 33.29 to NOK 31.34, reflecting analysts' refreshed assumptions around revenue growth, profit margins, the discount rate, and future P/E expectations. What's in the News Elkem has filed a follow on equity offering of NOK 299.999997 million, offering 11,111,111 ordinary shares at NOK 27 per share through a rights offering (Key Developments).ナラティブの更新 • Apr 25
ELK: New Three Division Structure And Workforce Cuts Will Support Upside
Analysts have made a small upward revision to Elkem's price target, moving it from NOK 33.14 to NOK 33.29. This reflects updated assumptions around revenue growth, profit margins and future P/E expectations.ナラティブの更新 • Apr 10
ELK: New Three Division Structure And Cost Cuts Will Drive Upside
The analyst price target for Elkem has moved slightly higher to NOK33.14 from NOK32.83, with analysts citing adjustments in the assumed discount rate, revenue growth, profit margin, and future P/E to support the change. What's in the News Elkem is introducing a new corporate structure with three divisions: Elkem Silicon, Elkem Foundry Alloys and Elkem Carbon.ナラティブの更新 • Mar 24
ELK: New Structure And Cost Cuts Will Support Future Upside
Analysts have kept their Elkem price target steady at NOK 32.83. They cite essentially unchanged assumptions for the discount rate, revenue growth, profit margin and future P/E as the basis for reaffirming their view.ナラティブの更新 • Mar 10
ELK: Safety Actions And Stable Earnings Assumptions Will Support Upside Potential
Analysts have kept their fair value estimate for Elkem unchanged at NOK 32.83, with only small tweaks to assumptions on discount rate, revenue growth, profit margin and future P/E, which feed into an updated price target narrative. What's in the News An extraordinary general meeting on 9 March 2026 approved an amendment to Section 4 of Elkem ASA's articles of association, confirming share capital at NOK 1,505,514,210 divided into 301,102,842 shares with a nominal value of NOK 5 each (Key Developments).ナラティブの更新 • Feb 23
ELK: Safety Actions And Earnings Assumptions Will Shape A Balanced Outlook
The analyst price target for Elkem has been adjusted from NOK 31.85 to NOK 32.83. Analysts cite updated assumptions across the discount rate, revenue growth, profit margin and forward P/E as the key drivers behind this change.ナラティブの更新 • Feb 09
ELK: Safety Reforms After Saint Fons Incident Will Support Upbeat Outlook
Narrative Update on Elkem Analysts have kept their fair value estimate for Elkem steady at NOK 31.85. They explain the unchanged price target by slightly adjusting their assumptions for discount rate, revenue growth, profit margin and future P/E expectations, rather than changing their overall view of the company’s valuation.ナラティブの更新 • Jan 25
ELK: Safety Incident And Minor Assumption Shifts Will Shape Balanced Outlook
Analysts have raised their fair value estimate for Elkem to €31.85 from €31.80, citing small adjustments to the discount rate, revenue growth, profit margin and forward P/E assumptions. What's in the News On 22 December 2025, an explosion occurred at a pilot workshop at the Elkem Silicones site in Saint Fons, Lyon, France, resulting in one employee losing his life and three others being injured (company report).ナラティブの更新 • Jan 10
ELK: Medical Materials Push And Ferrosilicon Cuts Will Shape Balanced Outlook
Analysts now estimate Elkem's fair value at €31.80 per share, slightly higher than the previous estimate of €31.00, citing small adjustments to their discount rate, revenue growth, profit margin and future P/E assumptions. What's in the News Explosion at Elkem's Saint Fons silicones pilot workshop in Lyon on 22 December 2025 resulted in one fatality and three injuries, with management cooperating with local authorities and providing psychological support to employees (Key Developments).ナラティブの更新 • Dec 25
ELK: Medical Materials Expansion And Ferrosilicon Curtailments Will Shape Measured Outlook
Analysts have raised their price target on Elkem to NOK 31.00 from NOK 29.80, reflecting updated assumptions of a slightly lower discount rate but higher future earnings multiples, despite somewhat softer expectations for revenue growth and profit margins. What's in the News Elkem ASA launched SILBIONE LSR Select EC 70, a next generation medical grade liquid silicone rubber engineered for wearable and diagnostic devices, combining high electrical conductivity, certified biocompatibility and enhanced process control (company announcement).ナラティブの更新 • Dec 11
ELK: Medical Materials Expansion And Production Cuts Will Shape Balanced Outlook
Analysts have modestly raised their price target on Elkem to NOK 29.80, citing slightly lower perceived risk reflected in a reduced discount rate, while keeping growth, margin, and valuation assumptions broadly unchanged. What's in the News Elkem launched SILBIONE LSR Select EC 70, a next generation medical grade liquid silicone rubber designed for wearable and diagnostic devices, featuring high electrical conductivity, certified biocompatibility, and enhanced process control for precision healthcare applications (Key Developments).ナラティブの更新 • Nov 27
ELK: New Medical-Grade Product Launch and Market Risks Will Shape Outlook
Analysts have maintained Elkem's fair value price target at NOK 29.80, citing stable underlying financial metrics and a slightly reduced discount rate as the basis for their decision. What's in the News Elkem ASA launched SILBIONE LSR Select EC 70, a next-generation medical-grade liquid silicone rubber designed for wearable and diagnostic devices.ナラティブの更新 • Nov 13
ELK: Upcoming Medical Material Launch Will Support Increased Market Confidence
Narrative Update on Elkem: Analyst Price Target Revision Analysts have maintained their fair value estimate for Elkem at NOK 29.80. This reflects steady confidence in the company despite minor adjustments to key assumptions such as profit margin and growth projections.ナラティブの更新 • Oct 29
Medical-Grade Silicone Launch and Production Cuts Will Balance Future Prospects
Analysts have raised their price target for Elkem from NOK 29.32 to NOK 29.80. This change reflects minor adjustments to their expectations for growth, discount rates, and profit margins.ナラティブの更新 • Oct 15
Silicones Review And Carbon Capture R&D Will Improve Competitiveness
Elkem's analyst consensus price target has been raised from $27.92 to $29.32, reflecting analysts' expectations of slightly improved revenue growth and a lower discount rate that drives upward fair value adjustments. Valuation Changes The consensus analyst price target has increased from NOK 27.92 to NOK 29.32.ナラティブの更新 • Sep 25
Silicones Review And Carbon Capture R&D Will Improve Competitiveness
Elkem's slight improvement in net profit margin has supported an upward revision of the consensus analyst price target from NOK26.40 to NOK27.92. What's in the News Elkem and NTE signed a long-term power purchase agreement for 300 GWh/year renewable power delivery (2028-2037) in Norway’s NO4 area.分析記事 • Sep 20
Earnings Tell The Story For Elkem ASA (OB:ELK)
With a price-to-earnings (or "P/E") ratio of 23.4x Elkem ASA ( OB:ELK ) may be sending very bearish signals at the...分析記事 • Jul 09
Is Now The Time To Look At Buying Elkem ASA (OB:ELK)?
While Elkem ASA ( OB:ELK ) might not have the largest market cap around , it received a lot of attention from a...分析記事 • Jun 17
Does Elkem (OB:ELK) Have A Healthy Balance Sheet?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...分析記事 • May 07
Shareholders Shouldn’t Be Too Comfortable With Elkem's (OB:ELK) Strong Earnings
Strong earnings weren't enough to please Elkem ASA's ( OB:ELK ) shareholders over the last week. We did some digging...分析記事 • Apr 29
Elkem (OB:ELK) Will Want To Turn Around Its Return Trends
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...分析記事 • Mar 24
Is It Too Late To Consider Buying Elkem ASA (OB:ELK)?
Elkem ASA ( OB:ELK ), might not be a large cap stock, but it saw a significant share price rise of 36% in the past...
新しいナラティブ • Feb 09
Carbon Capture Initiatives Will Strengthen ESG Positioning And Brand Value
Expansion in China and targeted operational improvements aim to boost EBITDA, enhancing revenue and earnings growth.分析記事 • Feb 05
Investors Still Aren't Entirely Convinced By Elkem ASA's (OB:ELK) Revenues Despite 26% Price Jump
The Elkem ASA ( OB:ELK ) share price has done very well over the last month, posting an excellent gain of 26%. While...分析記事 • Jan 23
Here's Why Elkem (OB:ELK) Is Weighed Down By Its Debt Load
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...分析記事 • Dec 19
Market Still Lacking Some Conviction On Elkem ASA (OB:ELK)
You may think that with a price-to-sales (or "P/S") ratio of 0.3x Elkem ASA ( OB:ELK ) is definitely a stock worth...分析記事 • Nov 02
There May Be Reason For Hope In Elkem's (OB:ELK) Disappointing Earnings
Soft earnings didn't appear to concern Elkem ASA's ( OB:ELK ) shareholders over the last week. Our analysis suggests...分析記事 • Oct 27
Elkem ASA Just Missed EPS By 51%: Here's What Analysts Think Will Happen Next
It's shaping up to be a tough period for Elkem ASA ( OB:ELK ), which a week ago released some disappointing...分析記事 • Sep 04
Little Excitement Around Elkem ASA's (OB:ELK) Revenues
You may think that with a price-to-sales (or "P/S") ratio of 0.4x Elkem ASA ( OB:ELK ) is definitely a stock worth...分析記事 • Aug 07
The Returns On Capital At Elkem (OB:ELK) Don't Inspire Confidence
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Ideally, a business will show two...分析記事 • Jul 17
Elkem ASA Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Elkem ASA ( OB:ELK ) investors will be delighted, with the company turning in some strong numbers with its latest...分析記事 • Jun 11
These 4 Measures Indicate That Elkem (OB:ELK) Is Using Debt In A Risky Way
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...分析記事 • May 27
Elkem ASA's (OB:ELK) Revenues Are Not Doing Enough For Some Investors
Elkem ASA's ( OB:ELK ) price-to-sales (or "P/S") ratio of 0.4x might make it look like a strong buy right now compared...分析記事 • May 11
Elkem ASA's (OB:ELK) Intrinsic Value Is Potentially 24% Below Its Share Price
Key Insights The projected fair value for Elkem is kr15.80 based on 2 Stage Free Cash Flow to Equity Current share...分析記事 • Apr 22
Analysts Have Made A Financial Statement On Elkem ASA's (OB:ELK) First-Quarter Report
Elkem ASA ( OB:ELK ) just released its latest first-quarter report and things are not looking great. It was a pretty...分析記事 • Apr 09
What Does Elkem ASA's (OB:ELK) Share Price Indicate?
Elkem ASA ( OB:ELK ), is not the largest company out there, but it saw a double-digit share price rise of over 10% in...分析記事 • Dec 15
Is Elkem (OB:ELK) A Risky Investment?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...分析記事 • Oct 23
Why Elkem ASA (OB:ELK) Could Be Worth Watching
Elkem ASA ( OB:ELK ), might not be a large cap stock, but it saw significant share price movement during recent months...収支内訳
収支内訳
Elkem の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 31 Mar 26 | 16,306 | 331 | 2,870 | 0 |
| 31 Dec 25 | 16,535 | 301 | 2,898 | 0 |
| 30 Sep 25 | 16,901 | 484 | 2,931 | 0 |
| 30 Jun 25 | 16,980 | 699 | 2,887 | 0 |
| 31 Mar 25 | 17,458 | 2,123 | 2,831 | 0 |
| 31 Dec 24 | 17,810 | 2,026 | 2,792 | 0 |
| 30 Sep 24 | 8,308 | 3,256 | 878 | 0 |
| 30 Jun 24 | 11,900 | 2,367 | 1,438 | 0 |
| 31 Mar 24 | 16,058 | 1,085 | 2,080 | 0 |
| 31 Dec 23 | 21,134 | 1,999 | 2,683 | 0 |
| 30 Sep 23 | 36,517 | 1,427 | 5,168 | 0 |
| 30 Jun 23 | 39,820 | 4,929 | 5,159 | 0 |
| 31 Mar 23 | 42,988 | 7,855 | 5,062 | 0 |
| 31 Dec 22 | 45,017 | 9,561 | 4,979 | 0 |
| 30 Sep 22 | 45,073 | 10,631 | 4,914 | 0 |
| 30 Jun 22 | 42,671 | 8,956 | 4,846 | 0 |
| 31 Mar 22 | 37,733 | 6,602 | 4,728 | 0 |
| 31 Dec 21 | 33,083 | 4,628 | 4,578 | 0 |
| 30 Sep 21 | 29,779 | 2,770 | 4,438 | 0 |
| 30 Jun 21 | 26,856 | 1,294 | 4,219 | 0 |
| 31 Mar 21 | 25,387 | 672 | 4,110 | 0 |
| 31 Dec 20 | 24,025 | 239 | 4,060 | 0 |
| 30 Sep 20 | 22,498 | 150 | 3,919 | 0 |
| 30 Jun 20 | 22,260 | 460 | 3,914 | 0 |
| 31 Mar 20 | 22,204 | 616 | 3,819 | 0 |
| 31 Dec 19 | 22,245 | 855 | 3,727 | 0 |
| 30 Sep 19 | 22,840 | 1,211 | 3,828 | 0 |
| 30 Jun 19 | 23,138 | 1,921 | 3,730 | 0 |
| 31 Mar 19 | 24,282 | 3,104 | 3,667 | 0 |
| 31 Dec 18 | 24,968 | 3,337 | 3,584 | 0 |
| 30 Sep 18 | 25,216 | 3,620 | 3,527 | 0 |
| 30 Jun 18 | 24,680 | 3,077 | 3,457 | 0 |
| 31 Mar 18 | 22,995 | 2,011 | 3,391 | 0 |
| 31 Dec 17 | 21,133 | 1,211 | 3,303 | 0 |
| 31 Dec 16 | 14,045 | 722 | 2,696 | 0 |
| 31 Dec 15 | 14,361 | 809 | 2,561 | 0 |
質の高い収益: ELKは 高品質の収益 を持っています。
利益率の向上: ELKの現在の純利益率 (2%)は、昨年(12.2%)よりも低くなっています。
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: ELKの収益は過去 5 年間で年間27.6%減少しました。
成長の加速: ELKは過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。
収益対業界: ELKは過去 1 年間で収益成長率がマイナス ( -84.4% ) となったため、 Chemicals業界平均 ( -1% ) と比較することが困難です。
株主資本利益率
高いROE: ELKの 自己資本利益率 ( 1.7% ) は 低い とみなされます。
総資産利益率
使用総資本利益率
過去の好業績企業の発掘
企業分析と財務データの現状
| データ | 最終更新日（UTC時間） |
|---|---|
| 企業分析 | 2026/05/22 07:04 |
| 終値 | 2026/05/22 00:00 |
| 収益 | 2026/03/31 |
| 年間収益 | 2025/12/31 |
データソース
企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。
| パッケージ | データ | タイムフレーム | 米国ソース例 |
|---|---|---|---|
| 会社財務 | 10年 |
| |
| アナリストのコンセンサス予想 | +プラス3年 |
|
|
| 市場価格 | 30年 |
| |
| 所有権 | 10年 |
| |
| マネジメント | 10年 |
| |
| 主な進展 | 10年 |
|
* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。
特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。
分析モデルとスノーフレーク
本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。
シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。
業界およびセクターの指標
私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。
アナリスト筋
Elkem ASA 4 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。9
| アナリスト | 機関 |
|---|---|
| null null | ABG Sundal Collier |
| Sebastian Satz | Citigroup Inc |
| Elliott Geoffrey Jones | Danske Bank |